Acyl-CoA metabolism and partitioning

Annual Review of Nutrition

Volumn 34, Issue , 2014, Pages 1-30

  Grevengoed, Trisha J ^a   Klett, Eric L ^b   Coleman, Rosalind A ^a  

^a IL   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Acyl CoA binding protein; Acyl CoA synthetase; Bubblegum; Cancer; Fatty acid binding protein; Fatty acid transport protein; Metabolic syndrome; Triacylglycerol; oxidation

Indexed keywords

ACYL COENZYME A; DIAZEPAM BINDING INHIBITOR; FATTY ACID; FATTY ACID BINDING PROTEIN; FATTY ACID TRANSPORT PROTEIN 1; FATTY ACID TRANSPORT PROTEIN 2; FATTY ACID TRANSPORT PROTEIN 3; FATTY ACID TRANSPORT PROTEIN 5; FATTY ACID TRANSPORT PROTEIN 6; FATTY ACID TRANSPORTER; FATTY ACID TRANSPORTER 4; GLYCEROLIPID; LONG CHAIN ACYL COENZYME A SYNTHETASE 1; LONG CHAIN ACYL COENZYME A SYNTHETASE 3; LONG CHAIN ACYL COENZYME A SYNTHETASE 4; LONG CHAIN ACYL COENZYME A SYNTHETASE 5; LONG CHAIN ACYL COENZYME A SYNTHETASE 6; LONG CHAIN FATTY ACID COENZYME A LIGASE; UNCLASSIFIED DRUG; ISOPROTEIN;

CARCINOGENESIS; ENZYME DEGRADATION; ENZYME METABOLISM; HUMAN; LIPOGENESIS; METABOLIC DISORDER; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEPLETION; REVIEW; ANIMAL; BIOLOGICAL MODEL; CELL MEMBRANE; ENDOPLASMIC RETICULUM; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; LIPID METABOLISM; METABOLISM; PROTEIN TRANSPORT;

ACYL COENZYME A; ANIMALS; CELL MEMBRANE; COENZYME A LIGASES; ENDOPLASMIC RETICULUM; FATTY ACID TRANSPORT PROTEINS; GENE EXPRESSION REGULATION; HUMANS; LIPID METABOLISM; MODELS, BIOLOGICAL; PROTEIN ISOFORMS; PROTEIN TRANSPORT;

EID: 84904645099     PISSN: 01999885     EISSN: 15454312     Source Type: Book Series    
DOI: 10.1146/annurev-nutr-071813-105541     Document Type: Review

References (207)

1. Achouri Y, Hegarty BD, Allanic D, Becard D, Hainault I, et al. 2005. Long chain fatty acyl-CoA synthetase 5 expression is induced by insulin and glucose: involvement of sterol regulatory element-binding protein-1c. Biochimie 87:1149-55
2. Banhegyi G, Csala M, Mandl J, Burchell A, Burchell B, et al. 1996. Fatty acyl-CoA esters and the permeability of rat liver microsomal vesicles. Biochem. J. 320(Part 1):343-44
3. Bell RM, Coleman RA. 1980. Enzymes of glycerolipid synthesis in eukaryotes. Annu. Rev. Biochem. 49:459-87
4. Black PN,DiRusso CC. 2003. Transmembrane movement of exogenous long-chain fatty acids: proteins, enzymes, and vectorial esterification. Microbiol. Mol. Biol. Rev. 67:454-72
5. Bloksgaard M, Bek S, Marcher AB, Neess D, Brewer J, et al. 2012. The acyl-CoA binding protein is required for normal epidermal barrier function in mice. J. Lipid Res. 53:2162-74
6. Bousette N, Kislinger T, Fong V, Isserlin R, Hewel JA, et al. 2009. Large-scale characterization and analysis of the murine cardiac proteome. J. Proteome Res. 8:1887-901
7. Bovolin P, Schlichting J, Miyata M, Ferrarese C, Guidotti A, Alho H. 1990. Distribution and characterization of diazepam binding inhibitor (DBI) in peripheral tissues of rat. Regul. Pept. 29:267-81
8. Brasaemle DL, Dolios G, Shapiro L, Wang R. 2004. Proteomic analysis of proteins associated with lipid droplets of basal and lipolytically stimulated 3T3-L1 adipocytes. J. Biol. Chem. 279:46835-42
9. Brocker C, Carpenter C, Nebert DW, Vasiliou V. 2010. Evolutionary divergence and functions of the human acyl-CoA thioesterase gene (ACOT) family. Hum. Genomics 4:411-20
10. Bu SY, Mashek DG. 2010. Hepatic long-chain acyl-CoA synthetase 5 mediates fatty acid channeling between anabolic and catabolic pathways. J. Lipid Res. 51:3270-80
11. Bu SY, Mashek MT, Mashek DG. 2009. Suppression of long chain acyl-CoA synthetase 3 decreases hepatic de novo fatty acid synthesis through decreased transcriptional activity. J. Biol. Chem. 284:30474-83
12. Cao Y, Dave KB, Doan TP, Prescott SM. 2001. Fatty acid CoA ligase 4 is up-regulated in colon adenocarcinoma. Cancer Res. 61:8429-34
13. Cao Y, Pearman AT, Zimmerman GA, McIntyre TM, Prescott SM. 2000. Intracellular unesterified arachidonic acid signals apoptosis. Proc. Natl. Acad. Sci. USA 97:11280-85
14. Capdevila JH, Falck JR, Harris RC. 2000. Cytochrome P450 and arachidonic acid bioactivation. Molecular and functional properties of the arachidonate monooxygenase. J. Lipid Res. 41:163-81
15. Caviglia JM, Li LO, Wang S, DiRusso CC, Coleman RA, Lewin TM. 2004. Rat long chain acyl-CoA synthetase 5, but not 1, 2, 3, or 4, complements Escherichia coli fadD. J. Biol. Chem. 279:11163-69
16. Chang YS, Tsai CT, Huangfu CA, Huang WY, Lei HY, et al. 2011. ACSL3 and GSK-3?are essential for lipid upregulation induced by endoplasmic reticulum stress in liver cells. J. Cell Biochem. 112:881-93
17. Chekroud K, Guillou L, Gregoire S, Ducharme G, Brun E, et al. 2012. Fatp1 deficiency affects retinal light response and dark adaptation, and induces age-related alterations. PLoS ONE 7:e50231
18. Chen MT, Kaufman LN, Spennetta T, Shrago E. 1992. Effects of high-fat feeding to rats on the interrelationship of body weight, plasma insulin, and fatty acyl-coenzyme A esters in liver and skeletal muscle. Metabolism 41:564-69
19. Chen S, Ogawa A, Ohneda M, Unger RH, Foster DW, McGarry JD. 1994. More direct evidence for a malonyl-CoA-carnitine palmitoyltransferase I interaction as a key event in pancreatic beta-cell signaling. Diabetes 43:878-83
20. Chiu HC, Kovacs A, Blanton RM, Han X, Courtois M, et al. 2005. Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy. Circ. Res. 96:225-33
21. Chiu HC, Kovacs A, Ford DA, Hsu FF, Garcia R, et al. 2001. A novel mouse model of lipotoxic cardiomyopathy. J. Clin. Invest. 107:813-22
22. Coe NR, Bernlohr DA. 1998. Physiological properties and functions of intracellular fatty acid-binding proteins. Biochim. Biophys. Acta 1391:287-306
23. Coe NR, Simpson MA, Bernlohr DA. 1999. Targeted disruption of the adipocyte lipid-binding protein (aP2 protein) gene impairs fat cell lipolysis and increases cellular fatty acid levels. J. Lipid Res. 40:967-72
24. Coleman RA, Haynes EB. 1983. Selective changes in microsomal enzymes of triacylglycerol and phosphatidylcholine synthesis in fetal and postnatal rat liver. Induction of microsomal sn-glycerol 3-phosphate and dihydroxyacetonephosphate acyltransferase activities. J. Biol. Chem. 258:450-56
25. Constantinides PP, Steim JM. 1985. Physical properties of fatty acyl-CoA. Critical micelle concentrations and micellar size and shape. J. Biol. Chem. 260:7573-80
26. Currie E, Schulze A, Zechner R, Walther TC, Farese RV Jr. 2013. Cellular fatty acid metabolism and cancer. Cell Metab. 18:153-61
27. Daikoku T, Shinohara Y, Shima A, YamazakiN, TeradaH. 1997. Dramatic enhancement of the specific expression of the heart-type fatty acid binding protein in rat brown adipose tissue by cold exposure. FEBS Lett. 410:383-86
28. de Jong H, Neal AC, Coleman RA, Lewin TM. 2007. Ontogeny of mRNA expression and activity of long-chain acyl-CoA synthetase (ACSL) isoforms in Mus musculus heart. Biochim. Biophys. Acta 1771:75-82
29. DigelM, Staffer S, Ehehalt F, StremmelW, Ehehalt R, Fullekrug J. 2011. FATP4 contributes as an enzyme to the basal and insulin-mediated fatty acid uptake of C2C12 muscle cells. Am. J. Physiol. Endocrinol. Metab. 301:E785-96
30. DiRusso CC, Li H, Darwis D,Watkins PA, Berger J, Black PN. 2005. Comparative biochemical studies of the murine fatty acid transport proteins (FATP) expressed in yeast. J. Biol. Chem. 280:16829-37
31. Doege H, Baillie RA, Ortegon AM, Tsang B, Wu Q, et al. 2006. Targeted deletion of FATP5 reveals multiple functions in liver metabolism: alterations in hepatic lipid homeostasis. Gastroenterology 130:1245-58
32. DoegeH,Grimm D, Falcon A,Tsang B, StormTA, et al. 2008. Silencing of hepatic fatty acid transporter protein 5 in vivo reverses diet-induced non-alcoholic fatty liver disease and improves hyperglycemia. J. Biol. Chem. 283:22186-92
33. DoegeH, Stahl A. 2006. Protein-mediated fatty acid uptake: novel insights from in vivo models. Physiology 21:259-68
34. Dong B, Kan CF, Singh AB, Liu J. 2013. High-fructose diet downregulates long-chain acyl-CoA synthetase 3 expression in liver of hamsters via impairingLXR/RXR signaling pathway. J. Lipid Res. 54:1241-54
35. Durgan DJ, Smith JK, Hotze MA, Egbejimi O, Cuthbert KD, et al. 2006. Distinct transcriptional regulation of long-chain acyl-CoA synthetase isoforms and cytosolic thioesterase 1 in the rodent heart by fatty acids and insulin. Am. J. Physiol. Heart Circ. Physiol. 290:H2480-97
36. Ellis BA, Poynten A, Lowy AJ, Furler SM, Chisholm DJ, et al. 2000. Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle. Am. J. Physiol. Endocrinol. Metab. 279:E554-60
37. Ellis JM, Li LO, Wu PC, Koves TR, Ilkayeva O, et al. 2010. Adipose acyl-CoA synthetase-1 directs fatty acids toward beta-oxidation and is required for cold thermogenesis. Cell Metab. 12:53-64
38. Ellis JM, Mentock SM, Depetrillo MA, Koves TR, Sen S, et al. 2011. Mouse cardiac acyl coenzyme a synthetase 1 deficiency impairs fatty acid oxidation and induces cardiac hypertrophy. Mol. Cell. Biol. 31:1252-62
39. Erol E, Cline GW, Kim JK, Taegtmeyer H, Binas B. 2004. Nonacute effects of H-FABP deficiency on skeletal muscle glucose uptake in vitro. Am. J. Physiol. Endocrinol. Metab. 287:E977-82
40. Frgeman NJ,Knudsen J. 1997. Role of long-chain fatty acyl-CoA esters in the regulation ofmetabolism and in cell signalling. Biochem. J. 323:1-12
41. Falcon A, Doege H, Fluitt A, Tsang B,Watson N, et al. 2010. FATP2 is a hepatic fatty acid transporter and peroxisomal very long-chain acyl-CoA synthetase. Am. J. Physiol. Endocrinol. Metab. 299:E384-93
42. Farrell SO, Fiol CJ, Reddy JK, Bieber LL. 1984. Properties of purified carnitine acyltransferases of mouse liver peroxisomes. J. Biol. Chem. 259:13089-95
43. Frahm JL, Li LO, Grevengoed TJ, Coleman RA. 2011. Phosphorylation and acetylation of acyl-CoA synthetase-1. J. Proteomics Bioinform. 4:129-37
44. Fraisl P, Forss-Petter S, ZigmanM, Berger J. 2004. Murine bubblegum orthologue is a microsomal very long-chain acyl-CoA synthetase. Biochem. J. 377:85-93
45. Fujimoto Y, Itabe H, Kinoshita T, Homma KJ, Onoduka J, et al. 2007. Involvement of ACSL in local synthesis of neutral lipids in cytoplasmic lipid droplets in human hepatocyte HuH7. J. Lipid Res. 48:1280-92
46. Fujino T, Yamamoto T. 1992. Cloning and functional expression of a novel long-chain acyl-CoA synthetase expressed in brain. J. Biochem. 111:197-203
47. Fullekrug J, Ehehalt R, Poppelreuther M. 2012. Outlook: membrane junctions enable the metabolic trapping of fatty acids by intracellular acyl-CoA synthetases. Front. Physiol. 3:401
48. GaiggB,NeergaardTB, Schneiter R, Hansen JK, Faergeman NJ, et al. 2001. Depletion of acyl-coenzyme A-binding protein affects sphingolipid synthesis and causes vesicle accumulation and membrane defects in Saccharomyces cerevisiae. Mol. Biol. Cell 12:1147-60
49. Gajda AM, Zhou YX, Agellon LB, Fried SK, Kodukula S, et al. 2013. Direct comparison of mice null for liver- or intestinal fatty acid binding proteins reveals highly divergent phenotypic responses to high-fat feeding. J. Biol. Chem. 288:30330-44
50. Garcia-Martinez C, Marotta M, Moore-Carrasco R, Guitart M, Camps M, et al. 2005. Impact on fatty acid metabolism and differential localization of FATP1 and FAT/CD36 proteins delivered in cultured human muscle cells. Am. J. Physiol. Cell Physiol. 288:C1264-72
51. Gargiulo CE, Stuhlsatz-Krouper SM, Schaffer JE. 1999. Localization of adipocyte long-chain fatty acyl- CA synthetase at the plasma membrane. J. Lipid Res. 40:881-92
52. Gimeno RE. 2007. Fatty acid transport proteins. Curr. Opin. Lipidol. 18:271-76
53. Gimeno RE, Ortegon AM, Patel S, Punreddy S, Ge P, et al. 2003. Characterization of a heart-specific fatty acid transport protein. J. Biol. Chem. 278:16039-44
54. Golej DL, Askari B, Kramer F, Barnhart S, Vivekanandan-Giri A, et al. 2011. Long-chain acyl-CoA synthetase 4 modulates prostaglandin E(2) release from human arterial smooth muscle cells. J. Lipid Res. 52:782-93
55. GolovkoMY, Rosenberger TA, FaergemanNJ, Feddersen S, Cole NB, et al. 2006. Acyl-CoA synthetase activity links wild-type but not mutant alpha-synuclein to brain arachidonate metabolism. Biochemistry 45:6956-66
56. Grimsrud PA, Carson JJ, Hebert AS, Hubler SL, Niemi NM, et al. 2012. A quantitative map of the liver mitochondrial phosphoproteome reveals posttranslational control of ketogenesis. CellMetab. 16:672-83
57. Gu SM, Thompson DA, Srikumari CR, Lorenz B, Finckh U, et al. 1997. Mutations in RPE65 cause autosomal recessive childhood-onset severe retinal dystrophy. Nat. Genet. 17:194-97
58. Gulick AM, Starai VJ, Horswill AR, Homick KM, Escalante-Semerena JC. 2003. The 1.75 A crystal structure of acetyl-CoA synthetase bound to adenosine-5-propylphosphate and coenzymeA. Biochemistry 42:2866-73
59. Hall M, Saggerson ED. 1985. Reversible inactivation by noradrenaline of long-chain fatty acyl-CoA synthetase in rat adipocytes. Biochem. J. 226:275-82
60. Hatch GM, Smith AJ, Xu FY, Hall AM, Bernlohr DA. 2002. FATP1 channels exogenous FA into 1,2,3- triacyl-sn-glycerol and down-regulates sphingomyelin and cholesterol metabolism in growing 293 cells. J. Lipid Res. 43:1380-89
61. Haunerland NH, Spener F. 2004. Fatty acid-binding proteins-insights from genetic manipulations. Prog. Lipid Res. 43:328-49
62. Heinzer AK, Watkins PA, Lu JF,Kemp S,Moser AB, et al. 2003. A very long-chain acyl-CoA synthetasedeficient mouse and its relevance to X-linked adrenoleukodystrophy. Hum. Mol. Genet. 12:1145-54
63. Hertz R, Magenheim J, Berman I, Bar-Tana J. 1998. Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4?. Nature 392:512-16
64. Hisanaga Y, AgoH,NakagawaN,Hamada K, Ida K, et al. 2004. Structural basis of the substrate-specific two-step catalysis of long chain fatty acyl-CoA synthetase dimer. J. Biol. Chem. 279:31717-26
65. Holloway GP, Chou CJ, Lally J, Stellingwerff T, Maher AC, et al. 2011. Increasing skeletal muscle fatty acid transport protein 1 (FATP1) targets fatty acids to oxidation and does not predispose mice to diet-induced insulin resistance. Diabetologia 54:1457-67
66. Horton JD, Shah NA, Warrington JA, Anderson NN, Park SW, et al. 2003. Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proc. Natl. Acad. Sci. USA 100:12027-32
67. Hotamisligil GS, Johnson RS, Distel RJ, Ellis R, Papaioannou VE, Spiegelman BM. 1996. Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 274:1377-79
68. Houmard JA, Tanner CJ, Yu C, Cunningham PG, Pories WJ, et al. 2002. Effect of weight loss on insulin sensitivity and intramuscular long-chain fatty acyl-CoAs in morbidly obese subjects. Diabetes 51:2959-63
69. Hsu KH, Powell GL. 1975. Inhibition of citrate synthase by oleoyl-CoA: a regulatory phenomenon. Proc. Natl. Acad. Sci. USA 72:4729-33
70. Hubbard B, Doege H, Punreddy S, Wu H, Huang X, et al. 2006. Mice deleted for fatty acid transport protein 5 have defective bile acid conjugation and are protected from obesity. Gastroenterology 130:1259-69
71. Hunt MC, Siponen MI, Alexson SE. 2012. The emerging role of acyl-CoA thioesterases and acyltransferases in regulating peroxisomal lipid metabolism. Biochim. Biophys. Acta 1822:1397-410
72. Hunt MC, Solaas K, Kase BF, Alexson SE. 2002. Characterization of an acyl-coA thioesterase that functions as a major regulator of peroxisomal lipid metabolism. J. Biol. Chem. 277:1128-38
73. Igal RA,Wang P,Coleman RA. 1997. TriacsinCblocks de novo synthesis of glycerolipids and cholesterol esters but not recycling of fatty acid into phospholipid: evidence for functionally separate pools of acyl- CoA. Biochem. J. 324:529-34
74. Jeppesen J, Jordy AB, Sjoberg KA, Fullekrug J, Stahl A, et al. 2012. Enhanced fatty acid oxidation and FATP4 protein expression after endurance exercise training in human skeletal muscle. PLoS ONE 7:e29391
75. Jepson CA, Yeaman SJ. 1992. Inhibition of hormone-sensitive lipase by intermediary lipid metabolites. FEBS Lett. 310:197-200
76. Jia Z, Moulson CL, Pei Z, Miner JH, Watkins PA. 2007. FATP4 is the principal very long-chain fatty acyl-CoA synthetase in skin fibroblasts. J. Biol. Chem. 282:20573-83
77. Jia Z, Pei Z, MaiguelD, Toomer CJ,Watkins PA. 2007. The fatty acid transport protein (FATP) family: very long chain acyl-CoA synthetases or solute carriers? J. Mol. Neurosci. 33:25-31
78. Jogl G, Hsiao YS, Tong L. 2005. Crystal structure of mouse carnitine octanoyltransferase and molecular determinants of substrate selectivity. J. Biol. Chem. 280:738-44
79. Johnson DR,Knoll JJ, Rowley N, Gordon JL. 1994. Genetic analysis of the role of Saccharomyces cerevisiae acyl-CoA synthetase genes in regulating protein N-myristoylation. J. Biol. Chem. 269:18037-46
80. Kang HW,NiepelMW, Han S, Kawano Y, Cohen DE. 2012. Thioesterase superfamily member 2/acyl- CoA thioesterase 13 (Them2/Acot13) regulates hepatic lipid and glucose metabolism. FASEB J. 26:2209-21
81. Kang MJ, Fujino T, Sasano H, Minekura H, Yabuki N, et al. 1997. A novel arachidonate-preferring acyl-CoA synthetase is present in steroidogenic cells of the rat adrenal, ovary, and testis. Proc. Natl. Acad. Sci. USA 94:2880-84
82. Kansara MS, Mehra AK, Von Hagen J, Kabotyansky E, Smith PJ. 1996. Physiological concentrations of insulin and T3 stimulate 3T3-L1 adipocyte acyl-CoA synthetase gene transcription. Am. J. Physiol. 270:E873-81
83. Kanter JE, Bornfeldt KE. 2013. Inflammation and diabetes-accelerated atherosclerosis: myeloid cell mediators. Trends Endocrinol. Metab. 24:137-44
84. Kanter JE, Kramer F, Barnhart S, Averill MM, Vivekanandan-Giri A, et al. 2012. Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis via acyl-CoA synthetase 1. Proc. Natl. Acad. Sci. USA 109:E715-24
85. Kanter JE, Tang C, Oram JF, Bornfeldt KE. 2012. Acyl-CoA synthetase 1 is required for oleate and linoleate mediated inhibition of cholesterol efflux through ATP-binding cassette transporter A1 in macrophages. Biochim. Biophys. Acta 1821:358-64
86. KimHC, Lee SW, Cho YY, Lim JM, Ryoo ZY, Lee EJ. 2009. RNA interference of long-chain acyl-CoA synthetase 6 suppresses the neurite outgrowth of mouse neuroblastoma NB41A3 cells. Mol. Med. Rep. 2:669-74
87. Kim JK, Fillmore JJ, Sunshine MJ, Albrecht B, Higashimori T, et al. 2004. PKC-theta knockout mice are protected from fat-induced insulin resistance. J. Clin. Invest. 114:823-27
88. Kim JK, Gimeno RE, Higashimor T, Kim HJ, Choi H, et al. 2004. Inactivation of fatty acid transport protein 1 prevents fat-induced insulin resistance in skeletal muscle. J. Clin. Invest. 113:756-63
89. Kirkby B, Roman N, Kobe B, Kellie S, Forwood JK. 2010. Functional and structural properties of mammalian acyl-coenzyme A thioesterases. Prog. Lipid Res. 49:366-77
90. Kislinger T, Gramolini AO. 2010. Proteome analysis of mouse model systems: a tool to model human disease and for the investigation of tissue-specific biology. J. Proteomics 73:2205-18
91. Klett EL, Chen S, Edin ML, Li LO, Ilkayeva O, et al. 2013. Diminished acyl-CoA synthetase isoform 4 activity in INS 832/13 cells reduces cellular epoxyeicosatrienoic acid levels and results in impaired glucose-stimulated insulin secretion. J. Biol. Chem. 288:21618-29
92. Krammer J, Digel M, Ehehalt F, StremmelW, Fullekrug J, Ehehalt R. 2011. Overexpression of CD36 and acyl-CoA synthetases FATP2, FATP4 and ACSL1 increases fatty acid uptake in human hepatoma cells. Int. J. Med. Sci. 8:599-614
93. Kuwata H, YoshimuraM, Sasaki Y, Yoda E, Nakatani Y, et al. 2013. Role of long-chain acyl-coenzyme A synthetases in the regulation of arachidonic acid metabolism in interleukin 1?-stimulated rat fibroblasts. Biochim. Biophys. Acta 1841:44-53
94. Landrock D, Atshaves BP,McIntosh AL, Landrock KK, Schroeder F, Kier AB. 2010. Acyl-CoA binding protein gene ablation induces pre-implantation embryonic lethality in mice. Lipids 45:567-80
95. Lee K, Kerner J, Hoppel CL. 2011. Mitochondrial carnitine palmitoyltransferase 1a (CPT1a) is part of an outer membrane fatty acid transfer complex. J. Biol. Chem. 286:25655-62
96. Lefebvre P, Cariou B, Lien F, Kuipers F, Staels B. 2009. Role of bile acids and bile acid receptors in metabolic regulation. Physiol. Rev. 89:147-91
97. Lehrer G, Panini SR, Rogers DH, Rudney H. 1981. Modulation of rat liver 3-hydroxy-3-methylglutaryl coenzyme A reductase by lipid inhibitors, substrates, and cytosolic factors. J. Biol. Chem. 256:5612-19
98. Lenz LS,Marx J,ChamulitratW,Kaiser I, GroneHJ, et al. 2011. Adipocyte-specific inactivation of Acyl- CoA synthetase fatty acid transport protein 4 (Fatp4) in mice causes adipose hypertrophy and alterations in metabolism of complex lipids under high fat diet. J. Biol. Chem. 286:35578-87
99. Lerner E, Shug AL, Elson C, Shrago E. 1972. Reversible inhibition of adenine nucleotide translocation by long chain fatty acyl coenzyme A esters in liver mitochondria of diabetic and hibernating animals. J. Biol. Chem. 247:1513-19
100. Lewin TM, Kim JH, Granger DA, Vance JE, Coleman RA. 2001. Acyl-CoA synthetase isoforms 1, 4, and 5 are present in different subcellular membranes in rat liver and can be inhibited independently. J. Biol. Chem. 276:24674-79
101. Lewin TM, Van Horn CG, Krisans SK, Coleman RA. 2002. Rat liver acyl-CoA synthetase 4 is a peripheral-membrane protein located in two distinct subcellular organelles, peroxisomes, and mitochondrial-associated membrane. Arch. Biochem. Biophys. 404:263-70
102. LewinTM, Wang S, NagleCA, Van Horn CG,Coleman RA. 2005. Mitochondrial glycerol-3-phosphate acyltransferase-1 directs the metabolic fate of exogenous fatty acids in hepatocytes. Am. J. Physiol. Endocrinol. Metab. 288:E835-44
103. Li LO, Ellis JM, Paich HA, Wang S, Gong N, et al. 2009. Liver-specific loss of long chain acyl-CoA synthetase-1 decreases triacylglycerol synthesis and beta-oxidation and alters phospholipid fatty acid composition. J. Biol. Chem. 284:27816-26
104. Li LO, Mashek DG, An J, Doughman SD, Newgard CB, Coleman RA. 2006. Overexpression of rat long chain acyl-CoA synthetase 1 alters fatty acid metabolism in rat primary hepatocytes. J. Biol. Chem. 281:37246-55
105. Li S, Lee J, Zhou Y, Gordon WC, Hill JM, et al. 2013. Fatty acid transport protein 4 (FATP4) prevents light-induced degeneration of cone and rod photoreceptors by inhibiting RPE65 isomerase. J. Neurosci. 33:3178-89
106. Li X, Gonzalez O, Shen X, Barnhart S, Kramer F, et al. 2013. Endothelial acyl-CoA synthetase 1 is not required for inflammatory and apoptotic effects of a saturated fatty acid-rich environment. Arterioscler. Thromb. Vasc. Biol. 33:232-40
107. Liang Y,Matschinsky FM. 1991. Content of CoA-esters in perifused rat islets stimulated by glucose and other fuels. Diabetes 40:327-33
108. Lin MH, Hsu FF, Miner JH. 2013. Requirement of fatty acid transport protein 4 for development, maturation, and function of sebaceous glands in a mouse model of ichthyosis prematurity syndrome. J. Biol. Chem. 288:3964-76
109. Lin MH, Khnykin D. 2014. Fatty acid transporters in skin development, function and disease. Biochim. Biophys. Acta. 1841:362-68
110. Liu L, Shi X, Bharadwaj KG, Ikeda S, Yamashita H, et al. 2009. DGAT1 expression increases heart triglyceride content but ameliorates lipotoxicity. J. Biol. Chem. 284:36312-23
111. Liu Z,Huang Y, Zhang Y,ChenD, Zhang YQ. 2011. Drosophila acyl-CoA synthetase long-chain family member 4 regulates axonal transport of synaptic vesicles and is required for synaptic development and transmission. J. Neurosci. 31:2052-63
112. Lobo S, Wiczer BM, Bernlohr DA. 2009. Functional analysis of long-chain acyl-CoA synthetase 1 in 3T3-L1 adipocytes. J. Biol. Chem. 284:18347-56
113. Makowski L, Hotamisligil GS. 2005. The role of fatty acid binding proteins in metabolic syndrome and atherosclerosis. Curr. Opin. Lipidol. 16:543-48
114. Maloberti PM, Duarte AB, Orlando UD, PasqualiniME, Solano AR, et al. 2010. Functional interaction between acyl-CoA synthetase 4, lipooxygenases and cyclooxygenase-2 in the aggressive phenotype of breast cancer cells. PLoS ONE 5:e15540
115. Marlhens F, Bareil C, Griffoin JM, Zrenner E, Amalric P, et al. 1997. Mutations in RPE65 cause Leber's congenital amaurosis. Nat. Genet. 17:139-41
116. Marszalek JR, Kitidis C,Dararutana A, Lodish HF. 2004. Acyl CoA synthetase 2 (ACS2) over-expression enhances fatty acid internalization and neurite outgrowth. J. Biol. Chem. 279:23882-91
117. Marszalek JR, KitidisC,Dirusso CC, Lodish HF. 2005. Long-chain acyl-CoA synthetase 6 preferentially promotes DHA metabolism. J. Biol. Chem. 280:10817-26
118. Martin G, Schoonjans K, Lefebvre AM, Staels B, Auwerx J. 1997. Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPARalpha and PPARgamma activators. J. Biol. Chem. 272:28210-17
119. Martin GG, Danneberg H, Kumar LS, Atshaves BP, Erol E, et al. 2003. Decreased liver fatty acid binding capacity and altered liver lipid distribution in mice lacking the liver fatty acid-binding protein gene. J. Biol. Chem. 278:21429-38
120. Martin GG, Huang H, Atshaves BP, Binas B, Schroeder F. 2003. Ablation of the liver fatty acid binding protein gene decreases fatty acyl CoA binding capacity and alters fatty acyl CoA pool distribution in mouse liver. Biochemistry 42:11520-32
121. Mashek DG, Bornfeldt KE, Coleman RA, Berger J, Bernlohr DA, et al. 2004. Revised nomenclature for the mammalian long chain acyl-CoA synthetase gene family. J. Lipid Res. 45:1958-61
122. Mashek DG, Coleman RA. 2006. Cellular fatty acid uptake: the contribution of metabolism. Curr. Opin. Lipidol. 17:274-78
123. Mashek DG, Li LO,Coleman RA. 2006. Rat long chain acyl-CoA synthetasemRNA, protein and activity vary in tissue distribution and in response to diet. J. Lipid Res. 47:2004-10
124. Mashek DG, Li LO, Coleman RA. 2007. Long-chain acyl-CoA synthetases and fatty acid channeling. Future Lipidol. 2:465-76
125. Mashima T, Oh-Hara T, Sato S, Mochizuki M, Sugimoto Y, et al. 2005. p53-defective tumors with a functional apoptosome-mediated pathway: a new therapeutic target. J. Natl. Cancer Inst. 97:765-77
126. McGarry JD, BrownNF. 1997. Themitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur. J. Biochem. 244:1-14
127. McGarry JD, Foster DW. 1979. In support of the roles of malonyl-CoA and carnitine acyltransferase I in the regulation of hepatic fatty acid oxidation and ketogenesis. J. Biol. Chem. 254:8163-68
128. McGarry JD, Foster DW. 1980. Regulation of hepatic fatty acid oxidation and ketone body production. Annu. Rev. Biochem. 49:395-420
129. Meller N, Morgan ME, Wong WP, Altemus JB, Sehayek E. 2013. Targeting of acyl-CoA synthetase 5 decreases jejunal fatty acid activation with no effect on dietary long-chain fatty acid absorption. Lipids Health Dis. 12:88
130. Meloni I, Muscettola M, RaynaudM, Longo I, Bruttini M, et al. 2002. FACL4, encoding fatty acid-CoA ligase 4, is mutated in nonspecific X-linked mental retardation. Nat. Genet. 30:436-40
131. Menendez JA, Lupu R. 2007. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat. Rev. Cancer 7:763-77
132. Mihalik SJ, Steinberg SJ, Pei Z, Park JH, Kim DG, et al. 2002. Participation of two members of the very long-chain acyl-CoA synthetase family in bile acid synthesis and recycling. J. Biol. Chem. 277:24771-79
133. Milger K, Herrmann T, Becker C, Gotthardt D, Zickwolf J, et al. 2006. Cellular uptake of fatty acids driven by the ER-localized acyl-CoA synthetase FATP4. J. Cell Sci. 119:4678-88
134. Min KT, Benzer S. 1999. Preventing neurodegeneration in the Drosophila mutant bubblegum. Science 284:1985-88
135. Mishima T, Miner JH, Morizane M, Stahl A, Sadovsky Y. 2011. The expression and function of fatty acid transport protein-2 and -4 in the murine placenta. PLoS ONE 6:e25865
136. Monaco ME, Creighton CJ, Lee P, Zou X, Topham MK, StafforiniDM. 2010. Expression of long-chain fatty acyl-CoA synthetase 4 in breast and prostate cancers is associated with sex steroid hormone receptor negativity. Transl. Oncol. 3:91-98
137. Moulson CL, LinMH, White JM, Newberry EP, DavidsonNO, Miner JH. 2007. Keratinocyte-specific expression of fatty acid transport protein 4 rescues the wrinkle-free phenotype in Slc27a4/Fatp4 mutant mice. J. Biol. Chem. 282:15912-20
138. MuoioDM, Lewin TM, Wiedmer P, Coleman RA. 2000. Acyl-CoAs are functionally channeled in liver: potential role of acyl-CoA synthetase. Am. J. Physiol. Endocrinol. Metab. 279:E1366-73
139. MuoioDM, Seefeld K,Witters LA, Coleman RA. 1999. AMP-activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver andmuscle: evidence that sn-glycerol-3-phosphate acyltransferase is a novel target. Biochem. J. 338(Part 3):783-91
140. Nagle CA, An J, Shiota M, Torres TP, Cline GW, et al. 2007. Hepatic overexpression of glycerol-sn- 3-phosphate acyltransferase 1 in rats causes insulin resistance. J. Biol. Chem. 282:14807-15
141. Nakamura Y, Sato T, Shiimura Y,Miura Y, Kojima M. 2013. FABP3 and brown adipocyte-characteristic mitochondrial fatty acid oxidation enzymes are induced in beige cells in a different pathway from UCP1. Biochem. Biophys. Res. Commun. 441:42-46
142. Nchoutmboube JA, Viktorova EG, Scott AJ, Ford LA, Pei Z, et al. 2013. Increased long chain acyl-CoA synthetase activity and fatty acid import is linked tomembrane synthesis for development of picornavirus replication organelles. PLoS Pathog. 9:e1003401
143. Neess D, Bloksgaard M, Bek S, Marcher AB, Elle IC, et al. 2011. Disruption of the acyl-CoA-binding protein gene delays hepatic adaptation to metabolic changes at weaning. J. Biol. Chem. 286:3460-72
144. Neschen S,Morino K,Hammond LE, Zhang D, Liu ZX, et al. 2005. Prevention of hepatic steatosis and hepatic insulin resistance in mitochondrial acyl-CoA:glycerol-sn-3-phosphate acyltransferase 1 knockout mice. Cell Metab. 2:55-65
145. Newberry EP, Xie Y, Kennedy S, Han X, Buhman KK, et al. 2003. Decreased hepatic triglyceride accumulation and altered fatty acid uptake in mice with deletion of the liver fatty acid-binding protein gene. J. Biol. Chem. 278:51664-72
146. NewmanCM,Magee AI. 1993. Posttranslational processing of theRas superfamily of small GTP-binding proteins. Biochim. Biophys. Acta 1155:79-96
147. Nikawa J, Tanabe T, OgiwaraH, Shiba T, Numa S. 1979. Inhibitory effects of long-chain acyl coenzyme A analogues on rat liver acetyl coenzyme A carboxylase. FEBS Lett. 102:223-26
148. Ning BF, Ding J, Yin C, ZhongW,Wu K, et al. 2010. Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinoma. Cancer Res. 70:7640-51
149. Obata Y, Fukumoto Y, Nakayama Y, Kuga T, Dohmae N, Yamaguchi N. 2010. The Lyn kinase Clobe mediates Golgi export of Lyn through conformation-dependent ACSL3 association. J. Cell Sci. 123:2649-62
150. Ogiwara H, Tanabe T, Nikawa J, Numa S. 1978. Inhibition of rat-liver acetyl-coenzyme-A carboxylase by palmitoyl-coenzyme A. Formation of equimolar enzyme-inhibitor complex. Eur. J. Biochem. 89:33-41
151. Oikawa E, Iijima H, Suzuki T, Sasano H, Sato H, et al. 1998. A novel acyl-CoA synthetase, ACS5, expressed in intestinal epithelial cells and proliferating preadipocytes. J. Biochem. 124:679-85
152. Okita RT, Okita JR. 2001. Cytochrome P450 4A fatty acid omega hydroxylases. Curr. Drug Metab. 2:265-81
153. Pei Z, Fraisl P, Berger J, Jia Z, Forss-Petter S, Watkins PA. 2004. Mouse very long-chain acyl-CoA synthetase 3/fatty acid transport protein 3 catalyzes fatty acid activation but not fatty acid transport in MA-10 cells. J. Biol. Chem. 279:54454-62
154. Pei Z, Fraisl P, Shi X, Gabrielson E, Forss-Petter S, et al. 2013. Very long-chain acyl-CoA synthetase 3: overexpression and growth dependence in lung cancer. PLoS ONE 8:e69392
155. Pei Z, Jia Z, Watkins PA. 2006. The second member of the human and murine "bubblegum" family is a testis- and brainstem-specific acyl-CoA synthetase. J. Biol. Chem. 281:6632-41
156. Pei Z, Oey NA, Zuidervaart MM, Jia Z, Li Y, et al. 2003. The acyl-CoA synthetase "bubblegum" (lipidosin): further characterization and role in neuronal fatty acid beta-oxidation. J. Biol.Chem. 278:47070-78
157. Pei Z, Sun P, Huang P, Lal B, Laterra J, Watkins PA. 2009. Acyl-CoA synthetase VL3 knockdown inhibits human glioma cell proliferation and tumorigenicity. Cancer Res. 69:9175-82
158. PfannerN,Glick BS, Arden SR, Rothman JE. 1990. Fatty acylation promotes fusion of transport vesicles with Golgi cisternae. J. Cell Biol. 110:955-61
159. Poppelreuther M, Rudolph B, Du C, Grossmann R, Becker M, et al. 2012. The N-terminal region of acyl-CoA synthetase 3 is essential for both the localization on lipid droplets and the function in fatty acid uptake. J. Lipid Res. 53:888-900
160. PrentkiM, Corkey BE. 1996. Are the ?-cell signaling molecules malonyl-CoA and cytosolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM? Diabetes 45:273-83
161. Prentki M, Joly E, El-Assaad W, Roduit R. 2002. Malonyl-CoA signaling, lipid partitioning, and glucolipotoxicity: role in beta-cell adaptation and failure in the etiology of diabetes. Diabetes 51(Suppl. 3):S405-13
162. Rasmussen JT, Borchers T, Knudsen J. 1990. Comparison of the binding affinities of acyl-CoA-binding protein and fatty-acid-binding protein for long-chain acyl-CoA esters. Biochem. J. 265:849-55
163. Redmond TM, Yu S, Lee E, Bok D, Hamasaki D, et al. 1998. Rpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle. Nat. Genet. 20:344-51
164. Rolf B, Oudenampsen-Kruger E, Borchers T, Faergeman NJ, Knudsen J, et al. 1995. Analysis of the ligand binding properties of recombinant bovine liver-type fatty acid binding protein. Biochim. Biophys. Acta 1259:245-53
165. Rosendal J, Ertbjerg P, Knudsen J. 1993. Characterization of ligand binding to acyl-CoA-binding protein. Biochem. J. 290(Part 2):321-26
166. Rubinow KB, Wall VZ, Nelson J,Mar D, Bomsztyk K, et al. 2013. Acyl-CoA synthetase 1 is induced by Gram-negative bacteria and lipopolysaccharide and is required for phospholipid turnover in stimulated macrophages. J. Biol. Chem. 288:9957-70
167. Schaffer JE, Lodish HF. 1994. Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein. Cell 79:427-36
168. Sebastian D, GuitartM, Garcia-Martinez C, Mauvezin C, Orellana-Gavalda JM, et al. 2009. Novel role of FATP1 in mitochondrial fatty acid oxidation in skeletal muscle cells. J. Lipid Res. 50:1789-99
169. Shanik MH, Xu Y, Skrha J, Dankner R, Zick Y, Roth J. 2008. Insulin resistance and hyperinsulinemia: Is hyperinsulinemia the cart or the horse? Diabetes Care 31(Suppl. 2):S262-68
170. Shearer J, Fueger PT, Bracy DP,Wasserman DH, Rottman JN. 2005. Partial gene deletion of heart-type fatty acid-binding protein limits the severity of dietary-induced insulin resistance. Diabetes 54:3133-39
171. Sheng Y, Tsai-Morris CH, Li J, DufauML. 2009. Lessons from the gonadotropin-regulated long chain acyl-CoA synthetase (GR-LACS) null mouse model: a role in steroidogenesis, but not result in X-ALD phenotype. J. Steroid Biochem. Mol. Biol. 114:44-56
172. Shim J, Moulson CL, Newberry EP, Lin MH, Xie Y, et al. 2009. Fatty acid transport protein 4 is dispensable for intestinal lipid absorption in mice. J. Lipid Res. 50:491-500
173. Shimomura I, Tokunaga K, Kotani K, Keno Y, Yansase-Fujiwara M, et al. 1993. Marked reduction of acyl-CoA synthetase activity and mRNA in intra-abdominal visceral fat by physical exercise. Am. J. Physiol. 265:E44-50
174. Shug A, Lerner E, Elson C, Shrago E. 1971. The inhibition of adenine nucleotide translocase activity by oleoyl CoA and its reversal in rat liver mitochondria. Biochem. Biophys. Res. Commun. 43:557-63
175. Simpson AE. 1997. The cytochrome P450 4 (CYP4) family. Gen. Pharmacol. 28:351-59
176. Sleeman MW, Donegan NP, Heller-Harrison R, LaneWS, Czech MP. 1998. Association of acyl-CoA synthetase-1 with GLUT4-containing vesicles. J. Biol. Chem. 273:3132-35
177. Smathers RL,PetersenDR. 2011. The human fatty acid-binding protein family: evolutionary divergences and functions. Hum. Genomics 5:170-91
178. Smith RH, Powell GL. 1986. The critical micelle concentration of some physiologically important fatty acyl-coenzyme A's as a function of chain length. Arch. Biochem. Biophys. 244:357-60
179. Soupene E, Kuypers FA. 2008. Mammalian long-chain acyl-CoA synthetases. Exp. Biol. Med. (Maywood) 233:507-21
180. Srere PA. 1987. Complexes of sequential metabolic enzymes. Methods Enzymol. 56:89-124
181. Stahl A, Hirsch DJ, Gimeno RE, Punreddy S, Ge P, et al. 1999. Identification of the major intestinal fatty acid transport protein. Mol. Cell 4:299-308
182. Stanimirov B, Stankov K, Mikov M. 2012. Pleiotropic functions of bile acids mediated by the farnesoid X receptor. Acta Gastroenterol. Belg. 75:389-98
183. Steinberg SJ, Mihalik SJ, Kim DG, Cuebas DA, Watkins PA. 2000. The human liver-specific homolog of very long-chain acyl-CoA synthetase is cholate:CoA ligase. J. Biol. Chem. 275:15605-8
184. Steinberg SJ, Morgenthaler J, Heinzer AK, Smith KD, Watkins PA. 2000. Very long-chain acyl-CoA synthetases: Human "bubblegum" represents a new family of proteins capable of activating very longchain fatty acids. J. Biol. Chem. 275:35162-69
185. Stinnett L, Lewin TM, Coleman RA. 2007. Mutagenesis of rat acyl-CoA synthetase 4 indicates amino acids that contribute to fatty acid binding. Biochim. Biophys. Acta 1771:119-25
186. Storch J, Thumser AE. 2010. Tissue-specific functions in the fatty acid-binding protein family. J. Biol. Chem. 285:32679-83
187. Sung YK, Hwang SY, ParkMK, Bae HI, KimWH, et al. 2003. Fatty acid-CoA ligase 4 is overexpressed in human hepatocellular carcinoma. Cancer Sci. 94:421-24
188. Sung YK, Park MK, Hong SH, Hwang SY, Kwack MH, et al. 2007. Regulation of cell growth by fatty acid-CoA ligase 4 in human hepatocellular carcinoma cells. Exp. Mol. Med. 39:477-82
189. Suzuki H, Kawarabayasi Y, Kondo J, Abe T, Nishikawa K, et al. 1990. Structure and regulation of rat long-chain acyl-CoA synthetase. J. Biol. Chem. 265:8681-85
190. Tang P-Z, Tsai-Morris C-H, Dufau ML. 2001. Cloning and characterization of a hormonally regulated rat long chain acyl-CoA synthetase. Proc. Natl. Acad. Sci. USA 98:6581-86
191. Tippett PS, Neet KE. 1982. Specific inhibition of glucokinase by long chain acyl coenzymes A below the critical micelle concentration. J. Biol. Chem. 257:12839-45
192. Tomoda H, Igarashi K, Omura S. 1987. Inhibition of acyl-CoA synthetase by triacsins. Biochim. Biophys. Acta 921:595-98
193. Tong F, Black PN, Coleman RA, DiRusso CC. 2006. Fatty acid transport by vectorial acylation in mammals: roles played by different isoforms of rat long-chain acyl-CoA synthetases. Arch. Biochem. Biophys. 447:46-52
194. Van Horn CG, Caviglia JM, Li LO, Wang S, Granger DA, Coleman RA. 2005. Characterization of recombinant long-chain rat acyl-CoA synthetase isoforms 3 and 6: identification of a novel variant of isoform 6. Biochemistry 44:1635-42
195. Vergnes L, Chin R, Young SG, Reue K. 2011. Heart-type fatty acid-binding protein is essential for efficient brown adipose tissue fatty acid oxidation and cold tolerance. J. Biol. Chem. 286:380-90
196. WangHW,Fang JS, KuangX,Miao LY,WangC, et al. 2012. Activity of long-chain acyl-CoA synthetase is required for maintaining meiotic arrest in Xenopus laevis. Biol. Reprod. 87:74
197. Watkins PA. 2008. Very-long-chain acyl-CoA synthetases. J. Biol. Chem. 283:1773-77
198. Watkins PA, Maiguel D, Jia Z, Pevsner J. 2007. Evidence for 26 distinct acyl-coenzyme A synthetase genes in the human genome. J. Lipid Res. 48:2736-50
199. Wendel AA, Cooper DE, Ilkayeva OR, Muoio DM, Coleman RA. 2013. Glycerol-3-phosphate acyltransferase (GPAT)-1, but not GPAT4, incorporates newly synthesized fatty acids into triacylglycerol and diminishes fatty acid oxidation. J. Biol. Chem. 288:27299-306
200. Wendel AA, Lewin TM, Coleman RA. 2009. Glycerol-3-phosphate acyltransferases: rate limiting enzymes of triacylglycerol biosynthesis. Biochim. Biophys. Acta 1791:501-6
201. Westin MA, Alexson SE, Hunt MC. 2004. Molecular cloning and characterization of two mouse peroxisome proliferator-activated receptor alpha (PPAR?)-regulated peroxisomal acyl-CoA thioesterases. J. Biol. Chem. 279:21841-48
202. Wu M, LiuH, ChenW, Fujimoto Y, Liu J. 2009. Hepatic expression of long-chain acyl-CoA synthetase 3 is upregulated in hyperlipidemic hamsters. Lipids 44:989-98
203. Wu Q, Kazantzis M, Doege H, Ortegon AM, Tsang B, et al. 2006. Fatty acid transport protein 1 is required for nonshivering thermogenesis in brown adipose tissue. Diabetes 55:3229-37
204. Wu Q, Ortegon AM, Tsang B, Doege H, Feingold KR, Stahl A. 2006. FATP1 is an insulin-sensitive fatty acid transporter involved in diet-induced obesity. Mol. Cell. Biol. 26:3455-67
205. YamashitaH,Wang Z,Wang Y, SegawaM, Kusudo T, Kontani Y. 2008. Induction of fatty acid-binding protein 3 in brown adipose tissue correlates with increased demand for adaptive thermogenesis in rodents. Biochem. Biophys. Res. Commun. 377:632-35
206. Zhan T, Poppelreuther M, Ehehalt R, Fullekrug J. 2012. Overexpressed FATP1, ACSVL4/FATP4 and ACSL1 increase the cellular fatty acid uptake of 3T3-L1 adipocytes but are localized on intracellular membranes. PLoS ONE 7:e45087
207. Zhang Y, Chen D,Wang Z. 2009. Analyses of mental dysfunction-related ACSl4 in Drosophila reveal its requirement for Dpp/BMP production and visual wiring in the brain. Hum. Mol. Genet. 18:3894-905